过去一年中添加的文章，按日期排序

Do Non-Dihydropyridine Calcium Channel Blockers Increase Bleeding Risk with Direct Oral Anticoagulants?

P Calvert, GYH Lip - Heart Rhythm, 2024 - Elsevier
58 天前 - … new concept – indeed, a pharmacokinetic study 10 years ago demonstrated a 1.4-fold
increase in apixaban … the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor …
相关文章 所有 4 个版本

Selection criteria for anticoagulants: survey of Japanese cardiologists based on their daily clinical practice–the Selection DOAC study

S Hashimoto, Y Motozawa, T Mano - Current Medical Research …, 2024 - Taylor & Francis
104 天前 - … DOACs with two classes of effect are available in Japan, including factor Xa
inhibitors (apixaban, edoxaban, and rivaroxaban) and thrombin inhibitors (dabigatran) [8, 9]. In …
相关文章 所有 3 个版本

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

M Di Nisio, M Candeloro, N Potere, E Porreca… - … and Vascular Biology, 2024 - btvb.org
127 天前 - … factor (F) Xa inhibitors, which include apixaban, edoxaban, and rivaroxaban. Most
guidelines recommend primary VTE prophylaxis with LMWH, apixaban, or … FXa inhibitors and …
相关文章

[引用][C] Direct oral anticoagulants: The new standard of care for cancer associated thrombosis

M Di Nisio, AY Lee - European Journal of Internal Medicine, 2024 - ejinme.com
196 天前 - … oral factor Xa inhibitors apixaban, … new evidence prompted international societies
to issue updated recommendations for the treatment of CAT to include oral factor Xa inhibitors …
相关文章 所有 3 个版本
[PDF] genesispub.org

[PDF][PDF] Complications of Tooth Extraction

G McCloskey - J Oral Med and Dent Res, 2024 - genesispub.org
相关文章 所有 2 个版本
[HTML] sciencedirect.com

[HTML][HTML] Insights from clinical trials: New evidence supports surgical interventions over drug therapies for atrial fibrillation

AD Modi, A Sharm, DM Modi - Medicine in Drug Discovery, 2024 - Elsevier
206 天前 - … apixaban, 1 received rivaroxaban, and 8 received dabigatran, all administered twice
daily [20]. Apixaban selectively inhibits factor Xa … such as warfarin, apixaban has a more …
相关文章

Venous thromboembolism-was is new in the revised AWMF guideline?

B Linnemann, KS Mühlberg… - Deutsche Medizinische …, 2024 - europepmc.org
207 天前 - … Weight restrictions are no longer recommended for apixaban and rivaroxaban,
but … In cancer-associated VTE, the direct factor Xa inhibitors are a good and safe alternative …
相关文章 所有 2 个版本
[PDF] springer.com

Effect of different anticoagulants and antiplatelets on intraoral bleeding time during professional oral hygiene session

P Pesce, L Pin, D Pin, F Bagnasco, L Ball, G Isola… - BMC Oral Health, 2024 - Springer
208 天前 - … new NOAC such as DTI: direct thrombin inhibitors (dabigatran) AntiXa: directa factor
Xa inhibitors (endoxaban, apixaban… orally as selective factor Xa inhibitors, boasting close to …
相关文章 所有 2 个版本

Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data

S Frol, JP Oblak, M Šabovič, P Kermer - CNS drugs, 2024 - Springer
210 天前 - … have been anticoagulated with factor Xa inhibitors (apixaban, rivaroxaban, edoxaban,
… done 15 h following the last dose of factor Xa inhibitors were eligible for the study. The …
被引用次数：2 相关文章 所有 4 个版本
[PDF] grandlab-jordan.com

[PDF][PDF] PROVOKED AND UNPROVOKED VENOUS THROMBOEMBOLISM

NA RUB - grandlab-jordan.com
232 天前 - … bleeding, using two new oral anticoagulants, namely, dabigatran and apixaban,
whose … Dabigatran and apixaban are direct inhibitors to thrombin and factor Xa, respectively. In …
相关文章